Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.795
+0.235 (9.18%)
Nov 9, 2026, 4:00 PM EST - Market closed
Pulmonx Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Pulmonx stock has a consensus rating of "Buy" and an average price target of $3.70. The average 1-year stock price forecast is 32.38% higher than the current stock price, while the lowest is $2.50 (-10.55%) and the highest is $5.00 (+78.89%).
Price Target: $3.70 (+32.38%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pulmonx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $5 | Buy | Reiterates | $5 | +78.89% | Oct 28, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Hold Maintains $3 | Hold | Maintains | $3 | +7.33% | Oct 28, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2.5 | Hold | Reiterates | $2.5 | -10.55% | Oct 28, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $2.5 → $4 | Buy | Reiterates | $2.5 → $4 | +43.11% | Oct 28, 2026 |
| Lake Street | Lake Street | Buy Reiterates $4 | Buy | Reiterates | $4 | +43.11% | Jul 30, 2026 |
Financial Forecast
Revenue This Year
90.79M
from 90.50M
Increased by 0.33%
Revenue Next Year
98.68M
from 90.79M
Increased by 8.68%
EPS This Year
-0.98
from -1.33
EPS Next Year
-0.92
from -0.98
EPS and Forward PE are based on non-GAAP adjusted numbers.